Skip to content

Detecting bleeding problems in patients who develop very high BP during Pregnancy

Role of Thromboelastography parameters in Hypertensive Disorders of Pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034324
Enrollment
181
Registered
2021-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

KMC Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For Cases - Singleton pregnancy with Severe Pre-eclampsia requiring immediate intervention Controls - Singleton pregnancy with Pre-eclampsia that can undergo expectant management

Exclusion criteria

Exclusion criteria: For Cases - Pre-eclampsia patients that can undergo expectant management, Multiple gestation, Any other causes of bleeding in pregnancy For Controls - Multiple gestation, Any other causes of bleeding in pregnancy, Patients with severe pre eclampsia and eclampsia

Design outcomes

Primary

MeasureTime frame
Identification of type of coagulopathy based on scores of R value, K value, â??aâ?? angle, MA, CI, Ly30 â?¢ R value - Represents period of time of latency from start of test to initial fibrin formation â?¢ K time - Represents time taken to achieve a certain level of clot strength - equates to amplitude 20 mm â?¢ Alpha Angle Measures the rapidity of fibrin build-up and cross-linking (clot strengthening) â?¢ MA - represents the ultimate strength of the fibrin clot Timepoint: 4 months

Secondary

MeasureTime frame
Providing Blood component as per result of TEG Further management as per protocol of hospital in high dependency unit.Timepoint: Outcome assessed every 8 weeks

Countries

India

Contacts

Public ContactDr Aparajita Sinha

KMC Manipal

drsapnagoni@rediffmail.com9880916061

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026